Safety and Efficiency Study of BCMA-PD1-CART Cells in Relapsed/Refractory Multiple Myeloma

Condition:   Multiple Myeloma Intervention:   Biological: BCMA-PD1-CART Cell Sponsor:   Chinese PLA General Hospital Recruiting

Source: ClinicalTrials.gov - November 14, 2019 Category: Research Source Type: clinical trials